Cargando…

Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management

SIMPLE SUMMARY: In previous studies, we described a modular Chimeric Antigen Receptor (CAR) T cell platform which we termed UniCAR. In contrast to conventional CARs, the interaction of UniCAR T cells does not occur directly between the CAR T cell and the tumor cell but is mediated via bispecific ada...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arndt, Claudia, Bergmann, Ralf, Striese, Franziska, Merkel, Keresztély, Máthé, Domokos, Loureiro, Liliana R., Mitwasi, Nicola, Kegler, Alexandra, Fasslrinner, Frederick, González Soto, Karla Elizabeth, Neuber, Christin, Berndt, Nicole, Kovács, Noemi, Szöllősi, David, Hegedűs, Nikolett, Tóth, Gyula, Emmermann, Jan-Philipp, Harikumar, Kuzhuvelil B., Kovacs, Tibor, Bachmann, Michael, Feldmann, Anja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027777/ https://www.ncbi.nlm.nih.gov/pubmed/35454902 http://dx.doi.org/10.3390/cancers14081996

Ejemplares similares

Targeting CD10 on B-Cell Leukemia Using the Universal CAR T-Cell Platform (UniCAR)
por: Mitwasi, Nicola, et al.
Publicado: (2022)

UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells
por: Arndt, Claudia, et al.
Publicado: (2020)

Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers
por: Loureiro, Liliana R., et al.
Publicado: (2020)

Critical reviews of immunotheranostics
por: Chen, Xiaoyuan, et al.
Publicado: (2020)

“UniCAR”-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells
por: Mitwasi, Nicola, et al.
Publicado: (2020)

Multimodal PET/MRI Imaging Results Enable Monitoring the Side Effects of Radiation Therapy
por: Kovács, Noémi, et al.
Publicado: (2018)

Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy
por: Kittel-Boselli, Enrico, et al.
Publicado: (2021)

Combining Radiation- with Immunotherapy in Prostate Cancer: Influence of Radiation on T Cells
por: Lindner, Diana, et al.
Publicado: (2022)

Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab(®)
por: Jureczek, Justyna, et al.
Publicado: (2020)

Adaptor CAR Platforms—Next Generation of T Cell-Based Cancer Immunotherapy
por: Arndt, Claudia, et al.
Publicado: (2020)

Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy
por: Feldmann, Anja, et al.
Publicado: (2020)

Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells
por: Saleh, Haidy A., et al.
Publicado: (2023)

Fluorescent, Prussian Blue-Based Biocompatible Nanoparticle System for Multimodal Imaging Contrast
por: Forgách, László, et al.
Publicado: (2020)

A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells
por: Kegler, Alexandra, et al.
Publicado: (2023)

Combined Cancer Immunotheranostic Nanomedicines: Delivery Technologies and Therapeutic Outcomes
por: Nasser, Tasneem A., et al.
Publicado: (2023)

Radiomic detection of microscopic tumorous lesions in small animal liver SPECT imaging
por: Veres, Dániel S., et al.
Publicado: (2019)

Preclinical Characterization of the (177)Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5
por: Striese, Franziska, et al.
Publicado: (2023)

Evaluation of Brain Nuclear Medicine Imaging Tracers in a Murine Model of Sepsis-Associated Encephalopathy
por: Szöllősi, Dávid, et al.
Publicado: (2018)

Thallium Labeled Citrate-Coated Prussian Blue Nanoparticles as Potential Imaging Agent
por: Szigeti, Krisztián, et al.
Publicado: (2018)

In situ lymphoma imaging in a spontaneous mouse model using the Cerenkov Luminescence of F-18 and Ga-67 isotopes
por: Ritter, Zsombor, et al.
Publicado: (2021)

The Correlation Between Platelet Count and Survival in Prostate Cancer
por: Mezei, Tünde, et al.
Publicado: (2022)

Synthesis and preclinical application of a Prussian blue-based dual fluorescent and magnetic contrast agent (CA)
por: Hegedűs, Nikolett, et al.
Publicado: (2022)

Correction: Synthesis and preclinical application of a Prussian blue-based dual fluorescent and magnetic contrast agent (CA)
por: Hegedűs, Nikolett, et al.
Publicado: (2023)

A Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity
por: Bartsch, Tabea, et al.
Publicado: (2021)

Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
por: Mitwasi, Nicola, et al.
Publicado: (2017)

Intraperitoneal Glucose Transport to Micrometastasis: A Multimodal In Vivo Imaging Investigation in a Mouse Lymphoma Model
por: Ritter, Zsombor, et al.
Publicado: (2021)

Enhancing Skin Cancer Immunotheranostics and Precision Medicine through Functionalized Nanomodulators and Nanosensors: Recent Development and Prospects
por: Farhana, Aisha
Publicado: (2023)

A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR
por: Arndt, Claudia, et al.
Publicado: (2019)

In Vitro Determination of Inhibitory Effects of Humic Substances Complexing Zn and Se on SARS-CoV-2 Virus Replication
por: Hajdrik, Polett, et al.
Publicado: (2022)

Thrombocytosis and Effects of IL-6 Knock-Out in a Colitis-Associated Cancer Model
por: Josa, Valeria, et al.
Publicado: (2020)

T cells engrafted with a UniCAR 28/z outperform UniCAR BB/z-transduced T cells in the face of regulatory T cell-mediated immunosuppression
por: Kegler, Alexandra, et al.
Publicado: (2019)

Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy
por: Jugniot, Natacha, et al.
Publicado: (2022)

An oligo-His-tag of a targeting module does not influence its biodistribution and the retargeting capabilities of UniCAR T cells
por: Jureczek, Justyna, et al.
Publicado: (2019)

Editorial: Targeting Pancreatic Cancer: Strategies and Hopes
por: Manu, Kanjoormana Aryan, et al.
Publicado: (2022)

Versatile Bispidine‐Based Bifunctional Chelators for (64)Cu(II)‐Labelling of Biomolecules
por: Singh, Garima, et al.
Publicado: (2020)

Correction: Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy
por: Jugniot, Natacha, et al.
Publicado: (2022)

TAMing pancreatic cancer: combat with a double edged sword
por: Lankadasari, Manendra Babu, et al.
Publicado: (2019)

Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells
por: Loureiro, L. R., et al.
Publicado: (2018)

Development of (177)Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen
por: Carpanese, Debora, et al.
Publicado: (2020)

Conventional CARs versus modular CARs
por: Feldmann, Anja, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_98fi3h96p5rm0d0afafsle5vta